FDA Says No To Street Drug Alternatives Posing As Supplements

Eileen Francis

首页> 外文期刊>The Rose Sheet: Toiletries, Fragrances and Skin Care >FDA Says No To Street Drug Alternatives Posing As Supplements

【24h】

FDA Says No To Street Drug Alternatives Posing As Supplements

机译：FDA向街头药物替代品拒绝作为补充剂

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

The agency warns Arco Globus Trading LLC to immediately stop marketing purported dietary supplements that it promotes as alternatives to illicit street drugs, including one with an active pharmaceutical antihistamine. The

机译：该机构警告ARCO Globus Trading LLC立即停止营销旨在促进营养补充剂，即它促进了非法街头药物的替代品，其中包括活性药物抗组胺药。这

著录项

来源
《The Rose Sheet: Toiletries, Fragrances and Skin Care》 |2017年第50期|共3页
作者
Eileen Francis;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类香料及化妆品工业;
关键词

相似文献

外文文献
中文文献
专利

1. FDA Says No To Street Drug Alternatives Posing As Supplements [J] . Eileen Francis The Rose Sheet: Toiletries, Fragrances and Skin Care . 2017,第50期

机译：FDA向街头药物替代品拒绝作为补充剂
2. Current FDA-Related Drug Information New Drugs Approved by the FDA New Dosage Forms and Indications Approved by the FDA Agents Pending FDA Approval New Drug/Biologies License Applications Filed by Manufacturer Supplemental Applications Filed by Manufacturer Significant Labeling Changes or "Dear Health Professional" Letters Related to Safety [J] . Danial E. Baker Hospital pharmacy. . 2010,第6期

机译：当前与FDA有关的药物信息由FDA批准的新药物，由FDA代理商批准的新剂型和适应症，待FDA批准的制造商提出的新药/生物许可申请，制造商提出的补充申请，重要的标签变更或与“亲爱的健康专业人员”的信件安全
3. Juries Trump FDA in Writing Drug Labels; FDA Grants Clinical Trial Permission for Human Embryonic Stem Cells; Alerts Issued for Two Biotechnology Products; Japanese Rheumatoid Arthritis Drug Approved in Europe; FDA Criticizes Humira Ad; Amgen's BLA for Bone Drug Accepted; Rules for Claiming Health Benefits from Food and Supplements [J] . Biotechnology Law Report . 2009,第2期

机译：陪审团特朗普FDA撰写药品标签； FDA授予人类胚胎干细胞临床试验许可；两种生物技术产品发出警报；日本在欧洲批准了类风湿关节炎药物； FDA批评Humira广告；接受了安进公司的骨药物BLA；从食品和补品中获取健康益处的规定
4. Using Machine Learning to Predict the Binding Dissociation of FDA Approved Drugs for Affinity- Based Drug Delivery Applications [C] . Edgardo Rivera-Delgado, Alison Xin, Horst A. von Recum Society for Biomaterials annual meeting and exposition . 2019

机译：使用机器学习预测基于亲和力的药物递送应用的FDA批准药物的结合解离
5. Role of Patient Advocacy Stakeholders in Science-Based Regulatory Policy at the U.S. Food and Drug Administration (FDA) [D] . Kuehn, Carrie Melissa. 2017

机译：患者倡导利益相关者在美国食品和药物管理局（FDA）的科学研究政策中的作用
6. The use of oral suspension and rationally prescribing alternatives may be supplemental to the implementation of clopidogrel new algorithm comprising CYP2C19 pharmacogenetics and drug interactions [O] . Meng Chen, Quan Zhou 2016

机译：口服混悬剂的使用和合理处方的补充可能是氯吡格雷新算法的实施的补充该新算法包括CYP2C19药物遗传学和药物相互作用
7. Study Of Scott Test Using Spectroscopic Techniques: An Alternative Method For Detecting Cocaine Hydrochloride And Its Addulterants In Street Drugs [estudo Do Teste De Scott Via Técnicas Espectroscópicas: Um Método Alternativo Para Diferenciar Cloridrato De Cocaína E Seus Adulterantes] [O] . Conceicao V.N., Souza L.M., Merlo B.B., 2015

机译：光谱技术对Scott试验的研究：一种检测街头毒品中盐酸可卡因及其添加剂的替代方法[通过光谱技术进行Scott试验的研究：区分盐酸可卡因及其掺杂剂的替代方法]
8. Patient and Physician Attitudes and Behaviors Associated With DTC Promotion of Prescription Drugs-Summary of FDA Survey Research Results. Appendix C: Supplemental Analyses [R] . 2004

机译：患者和医师对DTC推广处方药相关的态度和行为 - FDa调查研究结果摘要。附录C：补充分析

FDA Says No To Street Drug Alternatives Posing As Supplements

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅